Eosinophil lipid bodies: Specific, inducible intracellular sites for enhanced eicosanoid formation

Journal of Experimental Medicine

Volumn 186, Issue 6, 1997, Pages 909-920

  Bozza, Patricia T ^a,b   Yu, Wengui ^a,b   Penrose, John F ^c   Morgan, Ellen S ^a,b   Dvorak, Ann M ^a,b   Weller, Peter F ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ICOSANOID; LIPID; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LOCALIZATION; EOSINOPHIL; HUMAN; HUMAN CELL; LIPID ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; BINDING SITES; CELL NUCLEUS; EICOSANOIDS; ENZYME INHIBITORS; EOSINOPHILS; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INFLAMMATION MEDIATORS; LIPID METABOLISM; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; SIGNAL TRANSDUCTION;

EID: 0030930401     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.6.909     Document Type: Article

References (44)

1. Serhan, C.N. 1994. Eicosanoids in leukocyte function. Curr. Opin. Hematol. 1:69-77.
2. Henderson, W.R., Jr. 1994. the role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
3. Monta, I., M. Schindler, M.K. Regier, J.C. Otto, T. Hori, D.L. DeWitt, and W.L. Smith. 1995. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 270:10902-10908.
4. Otto, J.C., and W.L. Smith. 1994. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J. Biol. Chem. 269:19868-19875.
5. Smith, W.L., R.M. Garavito, and D.L. DeWitt. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:33157-33160.
6. Rouzer, C.A., and S. Kargman. 1988. Translocation of 5-Lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263:10980-10988.
7. Woods, J.W., J.F. Evans, D. Ethier, S. Scott, P.J. Vickers, L. Hearn, J.A. Heibein, S. Charleson, and I.I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
8. Reid, G.K., S. Kargman, P.J. Vickers, J.A. Mancini, C. Leveille, D. Ethier, D.K. Miller, J.W. Gillard, R.A. Dixon, and J.F. Evans. 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J. Biol. Chem. 265:19818-19823.
9. Brock, T.G., R. Paine III, and M. Peters-Golden. 1994. Localization ot 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J. Biol. Chem. 269:22059-22066.
10. Woods, J.W., M.J. Coffey, T.G. Brock, I.I. Singer, and M. Peters-Golden. 1995. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035-2046.
11. Serhan, C.N. 1996. Signalling the fat controller. Nature (Lond.). 384:23-24.
12. Coimbra, A., and A. Lopes-Vaz. 1971. The presence of lipid droplets and the absence ot stable sudanophilia in osmium-fixed human leukocytes. J. Histochem. Cytochem. 19:551-557.
13. Schlesinger, P.A., M.T. Stilman, and L. Peterson. 1982. Polyarthritis with birefringent lipid within synovial fluid microphages: case report and ultrastructural study. Arthritis Rheum. 25:1365-1368.
14. Weinstein, J. 1980. Synovial fluid leukocytosis associated with intracellular lipid inclusions. Arch. Intern. Med. 140:560-561.
15. Triggiani, M., A. Oriente, M.C. Seeds, D.A. Bass, G. Marone, and F.H. Chilton. 1995. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 182:1181-1190.
16. Robinson, J.M., M.L. Karnovsky, and M.J. Kamovsky. 1982. Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation. J. Cell Biol. 95:933-942.
17. Weller, P.F., R.A. Monahan-Earley, H.F. Dvorak, and A.M. Dvorak. 1991. Cytoplasmic lipid bodies of human eosinophils: subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 138:141-148.
18. Solley, G.O., J.E. Maldonado, G.J. Gleich, E.R. Giulani, H.C. Hoagland, R.V. Pierre, and A.L. Brown, Jr. 1976. Endomyocardiopathy with eosinophilia. Mayo Clin. Prof. 51: 697-708.
19. Beil, W.J., P.F. Weller, M.A. Peppercorn, and A.M. Dvorak. 1995. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonie Crohn's disease. J. Leukocyte Biol. 58:284-298.
20. Weller, P.F., S.J. Ackerman, A. Nicholson-Weller, and A.M. Dvorak. 1989. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 135:947-959.
21. Dvorak, A.M., E. Morgan, D.M. Tzizik, and P.P. Weller. 1994. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and murine 3T3 fibroblasts. Int. Arch. Allergy Immunol. 105:245-250.
22. Dvorak, A.M., E. Morgan, R.P. Schleimer, S.W. Ryeom, L.M. Lichtenstein, and P.F. Weller. 1992. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to nonmembrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes and neutrophils. J. Histochem. Cytochem. 40:759-769.
23. Dvorak, A.M., R.P. Schleimer, H.F. Dvorak, L.M. Lichtenstein, and P.F. Weller. 1992. Human lung mast cell and alveolar macrophage cytoplasmic lipid bodies contain arachidonic acid and prostaglandin endoperoxide synthase (cyclooxygenase). the substrate and enzyme necessary for prostaglandin production. Int. Arch. Allergy Immunol. 99:208-217.
24. Bozza, P.T., J.L. Payne, S.G. Morham, R. Langenbach, O. Smithies, and P.F. Weller. 1996. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA. 93: 11091-11096.
25. Bozza, P.T., J.L. Payne, J.L. Goulet, and P.F. Weller. 1996. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 183:1515-1525.
26. 4 synthase and preparation of a polyclonal antibody. Am. J. Respir. Crit. Care Med. 152:283-289.
27. Hansel, T.T., I.J.M. de Vries, T. Ift, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods. 145:105-110.
28. Roos, D., A.A. Voetman, and L.J. Meerhof. 1983. Functional activity of enucleated human polymorphonuclear leukocytes. J. Cell Biol. 97:368-377.
29. Qu-Hong, L.F. Brown, H.F. Dvorak, and A.M. Dvorak. 1997. Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J. Histochem. Cytochem. 45:21-33.
30. Pagano, R.E., and R.G. Sleight. 1985. Defining lipid transport pathways in animal cells. Science (Wash. DC). 229:1051-1057.
31. 4. Proc. Natl. Acad. Sci. USA. 80:7626-7630.
32. 4 synthase. Proc. Natl. Acad. Sci. USA. 89:11603-11606.
33. 4. Proc. Natl. Acad. Sci. USA. 91:7663-7667.
34. Braquet, P., L. Touqui, T. Shen, and B.B. Vargaftig. 1987. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:2-97.
35. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
36. Weller, P.F., S.W. Ryeom, S.T. Picard, S.J. Ackerman, and A.M. Dvorak. 1991. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell Biol. 113:137-146.
37. 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147-153.
38. MacGlashan, D., Jr., R.P. Schleimer, S.P. Peters, E.S. Schulman, G.K. Adams III, N.H. Newball, and L.M. Lichtenstein. 1982. Generation of leukotrienes by purified human lung mast cells. J. Clin. Invest. 70:747-751.
39. MacGlashan, D., Jr., S.P. Peters, J. Warner, and L.M. Lichtenstein. 1986. Characteristics of human basophil sulphidopeptide leukotriene release: reusability defined as the ability of the basophil to respond to dimer cross-links. J. Immnuol. 136:2231-2236.
40. 2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. J. Immunol. 141:2413-2419.
41. Dvorak, A.M., M.E. Hammond, E.S. Morgan, and H.F. Dvorak. 1980. Ultrastructural studies of macrophages: in vitro removal of cell coat with macrophage inhibition factor (MIF)-contammg lymphocyte culture supernatants; chloroform extraction, phospholipase digestion, and autoradiographic studies. J. Reticuloendothel. Soc. 27:119-142.
42. 2 activation in human neutrophils. Differential actions of diacylglycerols and alkylacylglycerols in priming cells for stimulation by N-formyl-met-leu-phe. J. Biol. Chem. 263: 16787-16795.
43. 2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. Biochim. Biophys. Acta. 1084:178-184.
44. Stewart, A.G., P.N. Dubbin, T. Harris, and G.J. Dusting. 1990. Platelet-activating factor may act as a second messenger in the relase of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc. Natl. Acad. Sci. USA. 87: 3215-3219.